<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">r-n-j</journal-id><journal-title-group><journal-title xml:lang="ru">Российский неврологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian neurological journal</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2658-7947</issn><issn pub-type="epub">2686-7192</issn><publisher><publisher-name>МИА</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.30629/2658-7947-2022-27-5-36-44</article-id><article-id custom-type="elpub" pub-id-type="custom">r-n-j-358</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ИССЛЕДОВАНИЯ И КЛИНИЧЕСКИЕ НАБЛЮДЕНИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>CLINICAL RESEARCHES AND CASE REPORTS</subject></subj-group></article-categories><title-group><article-title>Предикторы развития тромбоза глубоких вен нижних конечностей в остром периоде инсульта</article-title><trans-title-group xml:lang="en"><trans-title>Predictors of thrombosis development in the acute period of stroke</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5239-744X</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чазов</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Chazov</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p> Пермь </p></bio><bio xml:lang="en"><p> State Autonomous Institution of Health of Perm “City Clinical Hospital №4” </p><p> Perm </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5679-4100</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Мехряков</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Mekhryakov</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p> Пермь </p></bio><bio xml:lang="en"><p> Perm </p></bio><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6151-6412</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Павлова</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Pavlova</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p> Пермь </p></bio><bio xml:lang="en"><p> Perm </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6061-8118</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Кулеш</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kulesh</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p> Пермь </p></bio><bio xml:lang="en"><p> Perm </p></bio><email xlink:type="simple">aleksey.kulesh@gmail.com</email><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8305-1115</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сыромятникова</surname><given-names>Л. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Syromyatnikova</surname><given-names>L. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p> Пермь </p></bio><bio xml:lang="en"><p> Perm </p></bio><xref ref-type="aff" rid="aff-3"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7536-2060</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Каракулова</surname><given-names>Ю. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Karakulova</surname><given-names>J. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p> Пермь </p></bio><bio xml:lang="en"><p> Perm </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6310-9316</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шестаков</surname><given-names>В. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Shestakov</surname><given-names>V. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p> Пермь </p></bio><bio xml:lang="en"><p> Perm </p></bio><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Астанин</surname><given-names>П. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Astanin</surname><given-names>P. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p> Москва </p></bio><bio xml:lang="en"><p> Moscow </p></bio><xref ref-type="aff" rid="aff-4"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru">ФГБОУ ВО «Пермский государственный медицинский университет им. академика Е.А. Вагнера» Минздрава России<country>Россия</country></aff><aff xml:lang="en">Acad. E.A. Vagner Perm State Medical University, Ministry of Health of Russia<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru">ГАУЗ ПК «Городская клиническая больница №4»<country>Россия</country></aff><aff xml:lang="en">State Autonomous Institution of Health of Perm “City Clinical Hospital №4”<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-3"><aff xml:lang="ru">ФГБОУ ВО «Пермский государственный медицинский университет им. академика Е.А. Вагнера» Минздрава России; ГАУЗ ПК «Городская клиническая больница №4»<country>Россия</country></aff><aff xml:lang="en">Acad. E.A. Vagner Perm State Medical University, Ministry of Health of Russia; State Autonomous Institution of Health of Perm “City Clinical Hospital №4”<country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-4"><aff xml:lang="ru">ФГАОУ ВО «Российский национальный исследовательский медицинский университет имени Н.И. Пирогова» Минздрава России<country>Россия</country></aff><aff xml:lang="en">Federal State Autonomous Educational Institution of Higher Education “Russian National Research Medical University named after N.I. Pirogov” of the Ministry of Health of Russia<country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>24</day><month>11</month><year>2022</year></pub-date><volume>27</volume><issue>5</issue><fpage>36</fpage><lpage>44</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Чазов С.А., Мехряков С.А., Павлова А.В., Кулеш А.А., Сыромятникова Л.И., Каракулова Ю.В., Шестаков В.В., Астанин П.А., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Чазов С.А., Мехряков С.А., Павлова А.В., Кулеш А.А., Сыромятникова Л.И., Каракулова Ю.В., Шестаков В.В., Астанин П.А.</copyright-holder><copyright-holder xml:lang="en">Chazov S.A., Mekhryakov S.A., Pavlova A.V., Kulesh A.A., Syromyatnikova L.I., Karakulova J.V., Shestakov V.V., Astanin P.A.</copyright-holder><license license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.r-n-j.com/jour/article/view/358">https://www.r-n-j.com/jour/article/view/358</self-uri><abstract><sec><title>Введение</title><p>Введение. По данным зарубежных исследований, частота бессимптомного тромбоза глубоких вен (ТГВ) в остром периоде инсульта варьирует от 10 до 75%, клинически явного — от 2 до 10%. ТГВ является жизнеугрожающим осложнением, так как может привести к развитию тромбоэмболии легочной артерии (ТЭЛА).</p></sec><sec><title>Цель исследования</title><p>Цель исследования: выявить предикторы развития ТГВ нижних конечностей у пациентов с инсультом по данным регистра регионального сосудистого центра (РСЦ).</p></sec><sec><title>Материал и методы</title><p>Материал и методы. Обследованы 100 пациентов с инсультом, которые поступили в палаты/блок интенсивной терапии РСЦ с ноября по декабрь 2021 г. Помимо стандартного обследования, всем пациентам проводилось дуплексное сканирование вен нижних конечностей при поступлении и на 7-й день стационарного лечения.</p></sec><sec><title>Результаты</title><p>Результаты. Частота встречаемости ТГВ составила 13%. В сравнении с пациентами без ТГВ, пациентыс тромбозом характеризовались более высокими медианными значениями показателей возраста (77 vs 67 лет, p = 0,015), времени от развития инсульта до поступления в стационар (24 vs 5 часов, p = 0,026), тяжести инсульта по шкале NIHSS при поступлении (16 vs 5 баллов, p = 0,006) и завершении первого этапа лечения (10 vs 3 баллов, p = 0,010), двигательных нарушений в ноге по шкале Medical Research Council (4 vs 1 баллов, p = 0,011) и шкалы IMPROVE-VTE (4 vs 2 баллов, p &lt; 0,001). У половины пациентов с ТГВ тромбоз имел место уже при поступлении в стационар, у остальных возник в процессе лечения. У четверти пациентов тромбоз вовлекал проксимальные вены и осложнился у одного пациента развитием ТЭЛА, у остальных наблюдался дистальный ТГВ. Во всех случаях ТГВ развился в паретичной конечности. У всех пациентов тромбоз изначально расценен как бессимптомный и диагностирован только при дуплексном сканировании вен. К наиболее значимым факторам риска развития ТГВ в остром периоде инсульта отнесены возраст от 64 лет и выше (ОШ = 8,1), тяжесть инсульта по шкале NIHSS при поступлении от 6 баллов и выше (ОШ = 5,6), время до поступления от 10 часов и выше (ОШ = 3,8), сила в ноге не более 3 баллов (ОШ = 4,5) и результат шкалы IMPROVE-VTE от 3 баллов и выше (ОШ = 9,5). При построении логистической регрессионной модели с использованием выявленных факторов риска получены значения точности, равные 83% и 85% для обучающей и тестовой выборок соответственно.</p></sec><sec><title>Заключение</title><p>Заключение. ТГВ наблюдается у 13% пациентов в остром периоде инсульта и ассоциирован с возрастом пациентов, тяжестью инсульта и двигательных нарушений, временем от развития симптомов до поступления в стационар и риском венозных тромбоэмболических осложнений по шкале IMPROVE-VTE.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. According to foreign studies, the frequency of asymptomatic deep vein thrombosis (DVT) in the acute period of stroke varies from 10 to 75%, clinically obvious — from 2 to 10%. DVT is a life-threatening complication as it can lead to the development of pulmonary embolism (PE).</p></sec><sec><title>Purpose of the study</title><p>Purpose of the study: to identify predictors of DVT development in the lower extremities in patients with stroke according to the registry of the Regional Vascular Center (RVC).</p></sec><sec><title>Materials and methods</title><p>Materials and methods. 100 patients with stroke who were admitted to the wards/intensive care unit of the RVC from November to December 2021 were examined. In addition to the standard examination, all patients underwent duplex scanning of the veins of the lower extremities upon admission and on the 7th day of inpatient treatment.</p></sec><sec><title>Results</title><p>Results. The incidence of DVT was 13%. Compared with patients without DVT, patients with thrombosis were characterized by higher median values of age (77 vs 67 years, p = 0.015), time from stroke to hospital admission (24 vs 5 hours, p = 0.026), stroke severity by NIHSS score at admission (16 vs 5 points, p = 0.006) and completion of the first stage of treatment (10 vs 3 points, p = 0.010), movement disorders in the leg according to the Medical Research Council scale (4 vs 1 points, p = 0.011) and IMPROVE-VTE scales (4 vs 2 points, p &lt; 0.001). In half of patients with DVT, thrombosis occurred already at admission to the hospital, in the rest it occurred during treatment. In a quarter of patients, thrombosis involved the proximal veins and was complicated by the development of PE in one patient, the rest had distal DVT. In all cases, DVT developed in the paretic limb. In all patients, thrombosis was initially regarded as asymptomatic and was diagnosed only by duplex scanning of the veins. The most significant risk factors for developing DVT in the acute period of stroke were age 64 years and over (OR = 8.1), stroke severity on the NIHSS scale at admission of 6 points and above (OR = 5.6), time to admission from 10 hours or more (OR = 3.8), leg strength not more than 3 points (OR = 4.5) and an IMPROVE-VTE score of 3 points or more (OR = 9.5). When building a logistic regression model using the identified risk factors, accuracy values were obtained equal to 83% and 85% for the training and test samples, respectively.</p></sec><sec><title>Conclusion</title><p>Conclusion. DVT is observed in 13% of patients in the acute period of stroke and is associated with the age of patients, the severity of stroke and movement disorders, the time from the development of symptoms to hospital admission, and the risk of venous thromboembolic complications according to the IMPROVE-VTE scale.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>инсульт</kwd><kwd>тромбоз глубоких вен</kwd><kwd>ультразвуковая диагностика</kwd><kwd>предикторы</kwd></kwd-group><kwd-group xml:lang="en"><kwd>stroke</kwd><kwd>deep vein thrombosis</kwd><kwd>ultrasound diagnostics</kwd><kwd>predictors</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Liu L.P., Zheng H.G., Wang D.Z., Wang Y.L., Hussain M., Sun H.X. et al. Risk assessment of deep-vein thrombosis after acute stroke: a prospective study using clinical factors. CNS Neurosci Ther. 2014;20(5):403–10. https://doi.org/10.1111/cns.12227</mixed-citation><mixed-citation xml:lang="en">Liu L.P., Zheng H.G., Wang D.Z., Wang Y.L., Hussain M., Sun H.X. et al. Risk assessment of deep-vein thrombosis after acute stroke: a prospective study using clinical factors. CNS Neurosci Ther. 2014;20(5):403–10. https://doi.org/10.1111/cns.12227</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Dennis M., Caso V., Kappelle L.J., Pavlovic A., Sandercock P.; European Stroke Organisation. European Stroke Organisation( ESO) guidelines for prophylaxis for venous thromboembolism in immobile patients with acute ischaemic stroke. Eur Stroke J. 2016;1(1):6–19. https://doi.org/10.1177/2396987316628384</mixed-citation><mixed-citation xml:lang="en">Dennis M., Caso V., Kappelle L.J., Pavlovic A., Sandercock P.; European Stroke Organisation. European Stroke Organisation( ESO) guidelines for prophylaxis for venous thromboembolism in immobile patients with acute ischaemic stroke. Eur Stroke J. 2016;1(1):6–19. https://doi.org/10.1177/2396987316628384</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Rinde L.B., Småbrekke B., Mathiesen E.B., Løchen M.L., Njølstad I., Hald E.M. et al. Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study. J Am Heart Assoc. 2016;5(11):e004311. https://doi.org/10.1161/JAHA.116.004311</mixed-citation><mixed-citation xml:lang="en">Rinde L.B., Småbrekke B., Mathiesen E.B., Løchen M.L., Njølstad I., Hald E.M. et al. Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study. J Am Heart Assoc. 2016;5(11):e004311. https://doi.org/10.1161/JAHA.116.004311</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Khan MT, Ikram A, Saeed O, Afridi T, Sila CA, Smith MS, et al. Deep Vein Thrombosis in Acute Stroke — A Systemic Review of the Literature. Cureus. 2017;9(12):e1982. https://doi.org/10.7759/cureus.1982</mixed-citation><mixed-citation xml:lang="en">Khan MT, Ikram A, Saeed O, Afridi T, Sila CA, Smith MS, et al. Deep Vein Thrombosis in Acute Stroke — A Systemic Review of the Literature. Cureus. 2017;9(12):e1982. https://doi.org/10.7759/cureus.1982</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Cai Q., Zhang X., Chen H. Patients with venous thromboembolism after spontaneous intracerebral hemorrhage: a review. Thromb J. 2021;19(1):93. https://doi.org/10.1186/s12959-021-00345-z</mixed-citation><mixed-citation xml:lang="en">Cai Q., Zhang X., Chen H. Patients with venous thromboembolism after spontaneous intracerebral hemorrhage: a review. Thromb J. 2021;19(1):93. https://doi.org/10.1186/s12959-021-00345-z</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Dennis M., Sandercock P., Reid J., Graham C., Murray G., Venables G. et al. CLOTS Trials Collaboration. Can clinical features distinguish between immobile patients with stroke at high and low risk of deep vein thrombosis? Statistical modelling based on the CLOTS trials cohorts. J Neurol Neurosurg Psychiatry. 2011;82(10):1067–73. https://doi.org/10.1136/jnnp.2010.235945</mixed-citation><mixed-citation xml:lang="en">Dennis M., Sandercock P., Reid J., Graham C., Murray G., Venables G. et al. CLOTS Trials Collaboration. Can clinical features distinguish between immobile patients with stroke at high and low risk of deep vein thrombosis? Statistical modelling based on the CLOTS trials cohorts. J Neurol Neurosurg Psychiatry. 2011;82(10):1067–73. https://doi.org/10.1136/jnnp.2010.235945</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Mazzolai L., Aboyans V., Ageno W., Agnelli G., Alatri A., Bauersachs R. et al. Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function. Eur Heart J. 2018;39(47):4208–4218. https://doi.org/10.1093/eurheartj/ehx003</mixed-citation><mixed-citation xml:lang="en">Mazzolai L., Aboyans V., Ageno W., Agnelli G., Alatri A., Bauersachs R. et al. Diagnosis and management of acute deep vein thrombosis: a joint consensus document from the European Society of Cardiology working groups of aorta and peripheral vascular diseases and pulmonary circulation and right ventricular function. Eur Heart J. 2018;39(47):4208–4218. https://doi.org/10.1093/eurheartj/ehx003</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Spyropoulos A.C., Anderson F.A. Jr., FitzGerald G., Decousus H., Pini M., Chong B.H. et al.; IMPROVE Investigators. Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest. 2011;140(3):706–714. https://doi.org/10.1378/chest.10-1944</mixed-citation><mixed-citation xml:lang="en">Spyropoulos A.C., Anderson F.A. Jr., FitzGerald G., Decousus H., Pini M., Chong B.H. et al.; IMPROVE Investigators. Predictive and associative models to identify hospitalized medical patients at risk for VTE. Chest. 2011;140(3):706–714. https://doi.org/10.1378/chest.10-1944</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Needleman L., Cronan J.J., Lilly M.P., Merli G.J., Adhikari S., Hertzberg B.S. et al. Ultrasound for Lower Extremity Deep Venous Thrombosis: Multidisciplinary Recommendations From the Society of Radiologists in Ultrasound Consensus Conference. Circulation. 2018;137(14):1505–1515. https://doi.org/10.1161/CIRCULATIONAHA.117.030687</mixed-citation><mixed-citation xml:lang="en">Needleman L., Cronan J.J., Lilly M.P., Merli G.J., Adhikari S., Hertzberg B.S. et al. Ultrasound for Lower Extremity Deep Venous Thrombosis: Multidisciplinary Recommendations From the Society of Radiologists in Ultrasound Consensus Conference. Circulation. 2018;137(14):1505–1515. https://doi.org/10.1161/CIRCULATIONAHA.117.030687</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Mori T., Yoshioka K., Tanno Y. Frequency of deep vein thrombosis at admission for acute stroke and associated factors: a cross-sectional study. Thromb J. 2021;19(1):62. https://doi.org/10.1186/s12959-021-00315-5</mixed-citation><mixed-citation xml:lang="en">Mori T., Yoshioka K., Tanno Y. Frequency of deep vein thrombosis at admission for acute stroke and associated factors: a cross-sectional study. Thromb J. 2021;19(1):62. https://doi.org/10.1186/s12959-021-00315-5</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Liu X.C., Chen X.W., Li Z.L., Wang S.C., Chen C. Anatomical distribution of lower-extremity deep venous thrombosis in patients with acute stroke. J Stroke Cerebrovasc Dis. 2020;29(7):104866. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104866.</mixed-citation><mixed-citation xml:lang="en">Liu X.C., Chen X.W., Li Z.L., Wang S.C., Chen C. Anatomical distribution of lower-extremity deep venous thrombosis in patients with acute stroke. J Stroke Cerebrovasc Dis. 2020;29(7):104866. https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104866.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Liu Z., Liu D., Guo Z.N., Jin H., Sun T., Ni C., Yan X. Incidence and Risk Factors of Lower-Extremity Deep Vein Thrombosis After Thrombolysis Among Patients with Acute Ischemic Stroke. Pharmgenomics Pers Med. 2021;14:1107–1114. https://doi.org/10.2147/PGPM.S321084</mixed-citation><mixed-citation xml:lang="en">Liu Z., Liu D., Guo Z.N., Jin H., Sun T., Ni C., Yan X. Incidence and Risk Factors of Lower-Extremity Deep Vein Thrombosis After Thrombolysis Among Patients with Acute Ischemic Stroke. Pharmgenomics Pers Med. 2021;14:1107–1114. https://doi.org/10.2147/PGPM.S321084</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Dennis M., Mordi N., Graham C., Sandercock P.; CLOTS trials collaboration. The timing, extent, progression and regression of deep vein thrombosis in immobile stroke patients: observational data from the CLOTS multicenter randomized trials. J Thromb Haemost. 2011;9(11):2193–200. https://doi.org/10.1111/j.1538-7836.2011.04486.x</mixed-citation><mixed-citation xml:lang="en">Dennis M., Mordi N., Graham C., Sandercock P.; CLOTS trials collaboration. The timing, extent, progression and regression of deep vein thrombosis in immobile stroke patients: observational data from the CLOTS multicenter randomized trials. J Thromb Haemost. 2011;9(11):2193–200. https://doi.org/10.1111/j.1538-7836.2011.04486.x</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Morelli V.M., Sejrup JK., Småbrekke B.., Rinde L.B., Grimnes G., Isaksen T. et al. The Role of Stroke as a Trigger for Incident Venous Thromboembolism: Results from a Population-based Case-Crossover Study. TH Open. 2019;3(1):e50–e57. https://doi.org/10.1055/s-0039-1681020. PMID: 31249982; PMCID: PMC6524907.</mixed-citation><mixed-citation xml:lang="en">Morelli V.M., Sejrup JK., Småbrekke B.., Rinde L.B., Grimnes G., Isaksen T. et al. The Role of Stroke as a Trigger for Incident Venous Thromboembolism: Results from a Population-based Case-Crossover Study. TH Open. 2019;3(1):e50–e57. https://doi.org/10.1055/s-0039-1681020. PMID: 31249982; PMCID: PMC6524907.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Garg A., Dhanesha N., Shaban A., Samaniego EA.., Chauhan A.K., Leira E.C. Risk of Venous Thromboembolism in Hospitalized Patients with Acute Ischemic Stroke Versus Other Neurological Conditions. J Stroke Cerebrovasc Dis. 2021;30(11):106077. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.106077</mixed-citation><mixed-citation xml:lang="en">Garg A., Dhanesha N., Shaban A., Samaniego EA.., Chauhan A.K., Leira E.C. Risk of Venous Thromboembolism in Hospitalized Patients with Acute Ischemic Stroke Versus Other Neurological Conditions. J Stroke Cerebrovasc Dis. 2021;30(11):106077. https://doi.org/10.1016/j.jstrokecerebrovasdis.2021.106077</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Chu Q., Liao L., Wei W., Ye Z., Zeng L., Qin C., Tang Y. Venous Thromboembolism in ICU Patients with Intracerebral Hemorrhage: Risk Factors and the Prognosis After Anticoagulation Therapy. Int J Gen Med. 2021;14:5397–5404. https://doi.org/10.2147/IJGM.S327676</mixed-citation><mixed-citation xml:lang="en">Chu Q., Liao L., Wei W., Ye Z., Zeng L., Qin C., Tang Y. Venous Thromboembolism in ICU Patients with Intracerebral Hemorrhage: Risk Factors and the Prognosis After Anticoagulation Therapy. Int J Gen Med. 2021;14:5397–5404. https://doi.org/10.2147/IJGM.S327676</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Bembenek J., Karlinski M., Kobayashi A., Czlonkowska A. Early stroke-related deep venous thrombosis: risk factors and influence on outcome. J Thromb Thrombolysis. 2011;32(1):96–102. https://doi.org/10.1007/s11239-010-0548-3</mixed-citation><mixed-citation xml:lang="en">Bembenek J., Karlinski M., Kobayashi A., Czlonkowska A. Early stroke-related deep venous thrombosis: risk factors and influence on outcome. J Thromb Thrombolysis. 2011;32(1):96–102. https://doi.org/10.1007/s11239-010-0548-3</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Cheng H.R., Huang G.Q., Wu Z.Q., Wu Y.M., Lin G.Q., Song J.Y. et al. Individualized predictions of early isolated distal deep vein thrombosis in patients with acute ischemic stroke: a retrospective study. BMC Geriatr. 2021;21(1):140. https://doi.org/10.1186/s12877-021-02088-y</mixed-citation><mixed-citation xml:lang="en">Cheng H.R., Huang G.Q., Wu Z.Q., Wu Y.M., Lin G.Q., Song J.Y. et al. Individualized predictions of early isolated distal deep vein thrombosis in patients with acute ischemic stroke: a retrospective study. BMC Geriatr. 2021;21(1):140. https://doi.org/10.1186/s12877-021-02088-y</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
